| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/31/2005 | US20050070689 Nucleotide sequences coding transmembrane activator and CAML interactor (TACI) protein for use in treatment and prevention of autoimmune disorders |
| 03/31/2005 | US20050069988 Recombinant expression systems for production of low solubility foreign proteins specifically aminoglobulin |
| 03/31/2005 | US20050069983 Nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatment of herpes viral infection, cell proliferative and autoimmune disorders |
| 03/31/2005 | US20050069980 Transport protein for use as tool in altering in vivo pharmacokinetics of a pharmaceutical, toxic substance or xenobiotics by modulating an ability to transport acidic amino acids; antitumor agents |
| 03/31/2005 | US20050069979 Cell culture process |
| 03/31/2005 | US20050069975 Methods of enhancing yields of soluble proteins |
| 03/31/2005 | US20050069964 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/31/2005 | US20050069947 Antibodies specific for nanotubes and related methods and compositions |
| 03/31/2005 | US20050069945 Human chemotactic cytokine I polypeptides |
| 03/31/2005 | US20050069943 101 human secreted proteins |
| 03/31/2005 | US20050069942 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 03/31/2005 | US20050069919 Novel human secreted proteins and polynucleotides encoding the same |
| 03/31/2005 | US20050069888 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 03/31/2005 | US20050069883 Melanin-concentrating hormone receptor antagonist binding protein |
| 03/31/2005 | US20050069878 Proteins associated with cell growth, differentiation, and death |
| 03/31/2005 | US20050069877 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 03/31/2005 | US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders. |
| 03/31/2005 | US20050069866 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 03/31/2005 | US20050069562 Animal product free media and processes for obtaining a botulinum toxin |
| 03/31/2005 | US20050069554 Genetic engineered vitaxin monoclonal antibodies; prevention therapy of angiogenesis, restenosis |
| 03/31/2005 | US20050069542 Antibodies that specifically bind to GMAD |
| 03/31/2005 | US20050069535 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 03/31/2005 | US20050069534 Method of isolation and purification of trypsin from pronase protease and use thereof |
| 03/31/2005 | US20050069521 Enhancing the circulating half-life of interleukin-2 proteins |
| 03/31/2005 | CA2540138A1 Recombinant antibody against human insulin-like growth factor |
| 03/31/2005 | CA2540133A1 Drugs for treating cancer |
| 03/31/2005 | CA2539322A1 Kid3 and kid3 antibodies that bind thereto |
| 03/31/2005 | CA2539074A1 Campylobacter polypeptides and methods of use |
| 03/31/2005 | CA2538252A1 4'-thionucleosides and oligomeric compounds |
| 03/30/2005 | EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay |
| 03/30/2005 | EP1518937A1 Increasing the concentration of a nucleic acid molecule |
| 03/30/2005 | EP1518926A1 HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT |
| 03/30/2005 | EP1518864A2 Antibody against rhesus D |
| 03/30/2005 | EP1517913A2 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins |
| 03/30/2005 | EP1517699A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 03/30/2005 | EP1485404A4 Novel glucose 6-oxidases |
| 03/30/2005 | EP1224298B1 Fibrinolytically active polypeptide |
| 03/30/2005 | EP1200105B1 Modified factor viii |
| 03/30/2005 | EP1124570A4 Novel neuropilin/growth factor binding and uses thereof |
| 03/30/2005 | EP1047777B1 Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
| 03/30/2005 | EP0585415B1 Dna encoding a human 5-ht 1e receptor and uses thereof |
| 03/30/2005 | CN1602354A Human coagulation factor VII polypeptides |
| 03/30/2005 | CN1602317A Angiopoietin-2 specific binding agents |
| 03/30/2005 | CN1602204A Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 03/30/2005 | CN1600856A Method for constructing hybridoma cell line of heterogeneity of seereting human monoclonal antibody for anti hepatitis B |
| 03/30/2005 | CN1600369A Method for preparing targeting preparation of human monoclonal antibody crosslinking interferon for anti hepatitis b virus |
| 03/30/2005 | CN1195069C Process for preparing human follicle-stimualting hormone beta subunit monoclonal antibody |
| 03/30/2005 | CN1195068C Prepn for small peptide heme |
| 03/30/2005 | CN1195067C Method for extracting protein and chitin from fly maggot by using enxyme hydrolysis as well as preparing chitosan from chitin |
| 03/30/2005 | CN1195054C Nikemycin Z component engineering bacterium and its application |
| 03/29/2005 | US6872814 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/29/2005 | US6872811 HRPCa9 and HRPCa10 nucleic acids and polypeptides |
| 03/29/2005 | US6872563 Compositions and methods for production of disulfide bond containing proteins in host cells |
| 03/29/2005 | US6872557 Gene encoding novel human secretory phospholipase A2 |
| 03/29/2005 | US6872551 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/29/2005 | US6872549 From mammal cells transformed with cytomegalovirus vector using xanthine derivatives (caffeine and/or theobromine) and/or hexamethylene bisacetamide; serum-free |
| 03/29/2005 | US6872393 Polyalkylene oxide-modified single chain polypeptides |
| 03/29/2005 | US6872392 Humanized antibodies |
| 03/29/2005 | US6872391 Nucleotide sequences coding polypeptide for use in the treatment of eating disorders |
| 03/29/2005 | CA2323506C Mammalian blood loss-induced gene, kd312 |
| 03/29/2005 | CA2180950C Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
| 03/29/2005 | CA1341477C Method of reducing immunoglobulin e responses |
| 03/24/2005 | WO2005026192A2 Hpv cd8+ t-cell epitopes |
| 03/24/2005 | WO2005025516A2 Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates |
| 03/24/2005 | WO2005025497A2 Hpv cd8+ t-cell epitopes |
| 03/24/2005 | WO2005025494A2 Vaccine immunotherapy for immune suppressed patients |
| 03/24/2005 | WO2005012355B1 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis |
| 03/24/2005 | WO2004111194A3 Method to increase protein production in culture |
| 03/24/2005 | WO2004111074A9 In vivo production of a clostridial neurotoxin light chain peptide |
| 03/24/2005 | WO2004085463A3 Methods of unnatural amino acid incorporation in proteins in mammalian cells |
| 03/24/2005 | WO2004067554A3 Compositions and methods of tolerizing a primate to an antigen |
| 03/24/2005 | WO2004065569A3 Multi-functional antibodies |
| 03/24/2005 | WO2004065540A3 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 03/24/2005 | WO2003087134A3 G-protein coupled receptor ligands and methods |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | US20050065328 Gastrokines and derived peptides including inhibitors |
| 03/24/2005 | US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders |
| 03/24/2005 | US20050065107 Plasmids suitable for IL-2 expression |
| 03/24/2005 | US20050065084 polynucleotide codes for saratin polypeptides from saliva of leeches, used as antagonist for collagen-dependent platelet adhesion; genetic engineering; prophylaxis of cardiovascular disorders |
| 03/24/2005 | US20050064593 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 03/24/2005 | US20050064592 Cell extract for cell-free protein synthesis and process for producing the same |
| 03/24/2005 | US20050064572 Lipid kinase |
| 03/24/2005 | US20050064558 Chimeric polypeptide comprising functional differentially spliced interleukin receptor and b-cell differentiation factor for enhancing expression of interferon inducible protein (IP-10) and macrophage inflammarory proteins for use in treatment of viral diseases |
| 03/24/2005 | US20050064557 Method for producing proteins |
| 03/24/2005 | US20050064556 Transforming yeast cell with expression vector expressing gene coding tissue factor pathway inhibitor (TFPI) and tissue factor pathway inhibitor-2 (TFPI-2) for use as tool in treatment and prevention of thrombosis; bioreactors |
| 03/24/2005 | US20050064546 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
| 03/24/2005 | US20050064545 Transforming prokaryotic cells with expression vector comprising chaperone protein nucleotide sequences; identifying modulators for treatment and prevention of prion and neurodegenerative disorders |
| 03/24/2005 | US20050064544 Nucleotide sequences coding kinase for use as tool in identifying modulator for treatment and prevention of respiratory, cell proliferative, prostate, mammary gland and muscle disorders |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064540 Glycoprotein remodeling using endoglycanases |
| 03/24/2005 | US20050064539 Glycoprotein and process for producing the same |
| 03/24/2005 | US20050064530 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 03/24/2005 | US20050064493 Antibodies specific for vascular endothelial growth factor-B and DNA coding therefor |
| 03/24/2005 | US20050064491 Transport protein for use as tool in identifying modulator for treatment of sleep, nervous suystem, anixety, eating, cardiovascular and pain disordere |
| 03/24/2005 | US20050064475 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 03/24/2005 | US20050064460 Emulsion compositions |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |
| 03/24/2005 | US20050064445 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/24/2005 | US20050064404 Regulation of human serotonin-like g protein-coupled receptor |
| 03/24/2005 | US20050063993 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |